José-María Arguiñano

543 total citations
4 papers, 128 citations indexed

About

José-María Arguiñano is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, José-María Arguiñano has authored 4 papers receiving a total of 128 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Hematology, 3 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in José-María Arguiñano's work include Multiple Myeloma Research and Treatments (4 papers), Protein Degradation and Inhibitors (3 papers) and Cancer Treatment and Pharmacology (2 papers). José-María Arguiñano is often cited by papers focused on Multiple Myeloma Research and Treatments (4 papers), Protein Degradation and Inhibitors (3 papers) and Cancer Treatment and Pharmacology (2 papers). José-María Arguiñano collaborates with scholars based in Spain. José-María Arguiñano's co-authors include Laura Rosiñol, Juan José Lahuerta, Jesús F. San Miguel, María‐Victoria Mateos, Joan Bargay, Luis Palomera, Albert Oriol, Lucía López‐Corral, Bruno Paiva and Felipe de Arriba and has published in prestigious journals such as Blood, The Lancet Oncology and European Journal of Cancer.

In The Last Decade

José-María Arguiñano

4 papers receiving 127 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
José-María Arguiñano Spain	2	125	104	55	15	9	4	128
Riad Benramdane France	3	97 0.8×	54 0.5×	50 0.9×	21 1.4×	6 0.7×	4	110
Diamond Zuchlinski United States	4	99 0.8×	74 0.7×	44 0.8×	17 1.1×	3 0.3×	5	103
Claudia Polloni Italy	8	167 1.3×	136 1.3×	106 1.9×	22 1.5×	5 0.6×	16	189
Christopher Maisel United States	7	89 0.7×	79 0.8×	53 1.0×	15 1.0×	17 1.9×	20	127
Kristen Detweiler Short United States	3	149 1.2×	118 1.1×	81 1.5×	24 1.6×	9 1.0×	5	151
Antoni García‐Guiñón Spain	4	95 0.8×	64 0.6×	39 0.7×	41 2.7×	4 0.4×	7	105
Marinus van Marwijk-Kooy Netherlands	5	92 0.7×	89 0.9×	51 0.9×	11 0.7×	3 0.3×	8	110
J. Haessler United States	4	140 1.1×	116 1.1×	80 1.5×	14 0.9×	2 0.2×	7	147
Yana Lutska United States	7	144 1.2×	112 1.1×	96 1.7×	11 0.7×	3 0.3×	12	151
Kristin L Koenig United States	4	57 0.5×	40 0.4×	24 0.4×	23 1.5×	18 2.0×	13	98

Countries citing papers authored by José-María Arguiñano

Since Specialization

Citations

This map shows the geographic impact of José-María Arguiñano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José-María Arguiñano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José-María Arguiñano more than expected).

Fields of papers citing papers by José-María Arguiñano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José-María Arguiñano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José-María Arguiñano. The network helps show where José-María Arguiñano may publish in the future.

Co-authorship network of co-authors of José-María Arguiñano

This figure shows the co-authorship network connecting the top 25 collaborators of José-María Arguiñano. A scholar is included among the top collaborators of José-María Arguiñano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José-María Arguiñano. José-María Arguiñano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Ocio, Enrique M., Gabriela Bustamante, Ernesto Pérez Persona, et al.. (2023). Real-World Health Care Services Utilization Associated With the Management of Patients With Relapsed and Refractory Multiple Myeloma in Spain: The CharisMMa Study. Clinical Lymphoma Myeloma & Leukemia. 23(10). e341–e347. 1 indexed citations

2.

Mateos, María‐Victoria, Miguel‐Teodoro Hernández, Javier de la Rubia, et al.. (2022). Lenalidomide-dexamethasone versus observation in high-risk smoldering myeloma after 12 years of median follow-up time: A randomized, open-label study. European Journal of Cancer. 174. 243–250. 19 indexed citations

3.

Mateos, María‐Victoria, Miguel‐Teodoro Hernández, Pilar Giraldo, et al.. (2016). Lenalidomide plus dexamethasone versus observation in patients with high-risk smouldering multiple myeloma (QuiRedex): long-term follow-up of a randomised, controlled, phase 3 trial. The Lancet Oncology. 17(8). 1127–1136. 107 indexed citations

4.

Mateos, María‐Victoria, Pilar Giraldo, Javier de la Rubia, et al.. (2016). Sustained Overall Survival Benefit with Lenalidomide Plus Dexamethasone Versus No Treatment in Patients with Smoldering Myeloma at High Risk of Progression to Myeloma: Long Term Analysis. Blood. 128(22). 3308–3308. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact